NeoSCOPE RTTQA: pre-accrual and on-trial review of all patients in a UK oesophageal RT trial
RTTQA is required to ensure adherence to the outlining and planning aspects of the trial protocol as variations can lead to poorer outcomes. NeoSCOPE, a UK phase II randomized control trial of two neoadjuvant chemoradiotherapy regimens in oesophageal cancer, undertook a comprehensive RTTQA programme...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Elsevier
2018
|